Last edition
News about "Biocon Malaysia insulin facility"
Biocon Malaysia Gets MHRA Approval for Insulin Unit
Biocon has received UK MHRA approval for its new drug product fill-finish unit for Semglee (insulin glargine) at its Malaysia facility.
Biocon Malaysia Insulin Facility | 25/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members